Literature DB >> 7310380

Isolation of plaque variants differing in virulence from the 17D strain of yellow fever virus.

F Liprandi.   

Abstract

Two preparations of yellow fever vaccine (17D) were studied by clonal analysis. From one (17D-England) three types of clones were isolated, each differentiated by plaque size in Vero cells and virulence for intracerebrally inoculated mice: small plaque (SP) and large plaque (LP) clones were lethal, whereas medium plaque (MP) clones failed to kill at doses up to 10(6) p.f.u. Analysis of 24 randomly selected clones showed the original vaccine to be a mixture of predominantly MP and SP variants; 58% and 42% respectively. A single passage in suckling mice modified this composition to 90% SP and 10% LP variants. The response of six inbred strains of mice to intracerebral inoculation of the MP variant varied from complete resistance to complete susceptibility. From another 17D substrain (17D-South Africa) two types of variants were isolated (a SP avirulent type and a LP type of intermediate virulence), both different from the previously described variant.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7310380     DOI: 10.1099/0022-1317-56-2-363

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.

Authors:  C S Hahn; J M Dalrymple; J H Strauss; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

2.  A fluorescence-activatable reporter of flavivirus NS2B-NS3 protease activity enables live imaging of infection in single cells and viral plaques.

Authors:  Jorge L Arias-Arias; Derek J MacPherson; Maureen E Hill; Jeanne A Hardy; Rodrigo Mora-Rodríguez
Journal:  J Biol Chem       Date:  2020-01-09       Impact factor: 5.157

Review 3.  Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment.

Authors:  Thomas P Monath; Stephen J Seligman; James S Robertson; Bruno Guy; Edward B Hayes; Richard C Condit; Jean Louis Excler; Lisa Marie Mac; Baevin Carbery; Robert T Chen
Journal:  Vaccine       Date:  2014-10-27       Impact factor: 3.641

4.  Variability in Susceptibility to Type I Interferon Response and Subgenomic RNA Accumulation Between Clinical Isolates of Dengue and Zika Virus From Oaxaca Mexico Correlate With Replication Efficiency in Human Cells and Disease Severity.

Authors:  Tannya Karen Castro-Jiménez; Laura Cristina Gómez-Legorreta; Laura Alejandra López-Campa; Valeria Martínez-Torres; Marcos Alvarado-Silva; Araceli Posadas-Mondragón; Nallely Díaz-Lima; Hilda Arcelia Angulo-Mendez; Nancy R Mejía-Domínguez; Felipe Vaca-Paniagua; Federico Ávila-Moreno; Julio García-Cordero; Leticia Cedillo-Barrón; Sergio Roberto Aguilar-Ruíz; José Bustos-Arriaga
Journal:  Front Cell Infect Microbiol       Date:  2022-06-21       Impact factor: 6.073

5.  Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone.

Authors:  T J Chambers; M Nickells
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Neuroadapted yellow fever virus strain 17D: a charged locus in domain III of the E protein governs heparin binding activity and neuroinvasiveness in the SCID mouse model.

Authors:  Janice Nickells; Maria Cannella; Deborah A Droll; Yan Liang; William S M Wold; Thomas J Chambers
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

7.  Replication of virulent and attenuated strains of yellow fever virus in human monocytes and macrophage-like cells (U937).

Authors:  F Liprandi; R Walder
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

8.  Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice.

Authors:  Michael Nickells; Thomas J Chambers
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Analysis By Deep Sequencing of Discontinued Neurotropic Yellow Fever Vaccine Strains.

Authors:  Andrew S Beck; Thomas G Wood; Steven G Widen; Jill K Thompson; Alan D T Barrett
Journal:  Sci Rep       Date:  2018-09-07       Impact factor: 4.379

10.  A Fluorescent Real-Time Plaque Assay Enables Single-Cell Analysis of Virus-Induced Cytopathic Effect by Live-Cell Imaging.

Authors:  Jorge L Arias-Arias; Eugenia Corrales-Aguilar; Rodrigo A Mora-Rodríguez
Journal:  Viruses       Date:  2021-06-22       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.